Development of Central Nervous System Metastases in Patients with Advanced Non–Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or …

S Heon, BY Yeap, GJ Britt, DB Costa, MS Rabin… - Clinical cancer …, 2010 - AACR
Purpose: Gefitinib and erlotinib can penetrate into the central nervous system (CNS) and
elicit responses in patients with brain metastases (BM) from non–small cell lung cancer …
被引用次数：270 相关文章

Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib …

S Heon, BY Yeap, GJ Britt, DB Costa… - … Cancer Research: an …, 2010 - europepmc.org
Purpose Gefitinib and erlotinib can penetrate into the central nervous system (CNS) and
elicit responses in patients with brain metastases (BM) from non-small cell lung cancer …

Development of Central Nervous System Metastases in Patients with Advanced Non–Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or …

S Heon, BY Yeap, GJ Britt, DB Costa, MS Rabin… - Clinical Cancer …, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Gefitinib and erlotinib can penetrate
into the central nervous system (CNS) and elicit responses in patients with brain metastases …
[PDF] researchgate.net

[PDF][PDF] Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with …

S Heon, BY Yeap, GJ Britt, DB Costa, MS Rabin… - Clin Cancer …, 2010 - researchgate.net
Purpose—Gefitinib and erlotinib can penetrate into the central nervous system (CNS) and
elicit responses in patients with brain metastases (BM) from non-small cell lung cancer …

Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib

S Heon, BY Yeap, GJ Britt, DB Costa… - … : an official journal …, 2010 - pubmed.ncbi.nlm.nih.gov
Purpose Gefitinib and erlotinib can penetrate into the central nervous system (CNS) and
elicit responses in patients with brain metastases (BM) from non-small cell lung cancer …

[引用][C] Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with …

S HEON, BY YEAP, GJ BRITT… - Clinical cancer …, 2010 - pascal-francis.inist.fr
Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell
Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib CNRS Inist …
[HTML] nih.gov

[HTML][HTML] Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with …

S Heon, BY Yeap, GJ Britt, DB Costa… - … cancer research: an …, 2010 - ncbi.nlm.nih.gov
Purpose Gefitinib and erlotinib can penetrate into the central nervous system (CNS) and
elicit responses in patients with brain metastases (BM) from non-small cell lung cancer …

Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib …

S Heon, BY Yeap, GJ Britt, DB Costa… - … Cancer Research: an …, 2010 - europepmc.org
Purpose Gefitinib and erlotinib can penetrate into the central nervous system (CNS) and
elicit responses in patients with brain metastases (BM) from non-small cell lung cancer …

[引用][C] Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with …

S HEON, BY YEAP, GJ BRITT… - Clinical …, 2010 - American Association for Cancer …